SPC
TVRD

Slate Path Capital’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Slate Path Capital’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$16.4M Buy
+704,118
New +$16.4M 0.28% 37